A systematic review: Identifying the prevalence rates of psychiatric disorder in Australia’s Indigenous populations

Abstract

It was identified that there is limited evidence on the occurrence of psychiatric disorders for Indigenous people in the general community. More research in this area is essential to provide accurate and reliable estimates and to provide a baseline for evaluating the effectiveness of programs aimed at reducing the high mental health burden experienced by Indigenous Australians. Future research needs to ensure that standardised and validated methods are used to accurately estimate the prevalence of psychiatric disorders among Indigenous Australians.

Mood and anxiety disorders in Australia and New Zealand's indigenous populations: A systematic review and meta-analysis

“…Whilst the physical health of these groups is well-understood, mental health is not as well-researched however. Previous reviews have attempted to identify rates of psychiatric disorders in Indigenous Australians (Black et al, 2015) and New Zealanders (Baxter, 2008), with varying findings. For instance, Black et al found wide variability in the rates of psychiatric disorder for Indigenous Australians, with some studies reporting high rates (up to approximately 50% of participants) for anxiety and mood disorders.…”

The link between improved mental health outcomes for Indigenous Australians and relationships: what is the role of mental health nurses?

“…), and higher levels of psycopathology (Black et al . ). This has led to Indigenous leaders and researchers alike examining a range of solutions to the many complex issues involved (Ridani et al .…”

Condiciones sociodemográficas y perfil de salud de los adultos mayores indígenas del departamento de Nariño

“…Por lo anterior, entre los adultos mayores indígenas son frecuentes las enfermedades crónicas y son estas la causa principal de mortalidad. Asimismo, la prevalencia de trastornos mentales en estos contextos suele ser mayor en comparación con otros grupos poblacionales (5). Sin embargo, la incidencia de demencia y deterioro cognitivo leve todavía no se ha definido.…”